Showing results (191-200 of 553) with videos related to

Sort By:
Pageof 56
Molecular and Cellular Biology|March 25, 2000
The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexesC Rachez, M Gamble, C P Chang, et al.
Molecular Pharmacology|June 15, 2012
Cardiotonic steroids stabilize regulator of G protein signaling 2 protein levelsBenita Sjögren, Sergio Parra, Lauren J Heath, et al.
Melanoma Management|September 8, 2018
Bowel perforation associated with robust response to BRAF/MEK inhibitor therapy for BRAF-mutant melanoma: a case reportSamantha L Kass, Allison F Linden, Patrick G Jackson, et al.
Future Oncology (London, England)|April 20, 2022
Real-world treatment patterns and overall survival in BRAF-mutant melanoma patients treated with immunotherapy or targeted therapyMichael B Atkins, Cristina Julian, Matthew H Secrest, et al.
Blood|November 15, 1991
Complement activation in cancer patients undergoing immunotherapy with interleukin-2 (IL-2): binding of complement and C-reactive protein by IL-2-activated lymphocytesG Vachino, J A Gelfand, M B Atkins, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1996
Lag phase quantification for solid gastric emptying studiesH A Ziessman, F B Atkins, U S Vemulakonda, et al.
The Journal of Nursing Administration|October 1, 1992
Nursing research in the VA system. A consortium approachD Mays, K Devitt, T Gottlieb, et al.
The Journal of Investigative Dermatology|March 11, 2011
Long-term use of nonsteroidal anti-inflammatory drugs decreases the risk of cutaneous melanoma: results of a United States case-control studyClara Curiel-Lewandrowski, Tamar Nijsten, Maria L Gomez, et al.
Melanoma Research|September 9, 2010
Impact of concomitant immunosuppression on the presentation and prognosis of patients with melanomaAmy Frankenthaler, Ryan J Sullivan, Wei Wang, et al.
Synapse (New York, N.Y.)|July 10, 1999
Region-specific induction of deltaFosB by repeated administration of typical versus atypical antipsychotic drugsJ B Atkins, J Chlan-Fourney, H E Nye, et al.
Pageof 56